Creative Medical Technology filed a patent application covering synergy between intradiscal stem cell injections and stimulation of blood vessel formation around the spine.
ASC Biosciences partnered with Stem Cell Development Fund to receive US $1.5MM to support development and marketing of its Multipotent Adult Stem Cell platform.
Premier is now offering Bioventus’ full surgical orthobiologics product portfolio to its U.S. membership, comprising 3,750 hospitals and >130,000 provider organizations.Â
Trice Medical closed a US $19.3MM Series C financing. Funds will support U.S. marketing and ex-U.S. regulatory approvals for the mi-eye2™ system.
AMB Surgical received an investment to support prototype development of the Flyte Automated Growing Rod for the treatment of juvenile scoliosis, traumatic injuries, etc.